1. Home
  2. MATH vs DTIL Comparison

MATH vs DTIL Comparison

Compare MATH & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$1.13

Market Cap

82.9M

Sector

Finance

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$4.34

Market Cap

97.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
DTIL
Founded
2015
2006
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.9M
97.7M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
MATH
DTIL
Price
$1.13
$4.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
94.7K
154.1K
Earning Date
01-01-0001
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
106.52
EPS
N/A
N/A
Revenue
N/A
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$34.30
P/E Ratio
$3.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$3.53
52 Week High
$4.17
$8.82

Technical Indicators

Market Signals
Indicator
MATH
DTIL
Relative Strength Index (RSI) 31.34 59.29
Support Level N/A $4.17
Resistance Level $4.04 $4.61
Average True Range (ATR) 0.10 0.25
MACD 0.02 0.06
Stochastic Oscillator 29.39 94.34

Price Performance

Historical Comparison
MATH
DTIL

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: